Magnetar Financial’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-8,788
| Closed | -$2.54M | – | 728 |
|
2022
Q4 | $2.54M | Buy |
+8,788
| New | +$2.54M | 0.04% | 366 |
|
2022
Q1 | – | Sell |
-81,724
| Closed | -$17.9M | – | 1531 |
|
2021
Q4 | $17.9M | Buy |
81,724
+17,487
| +27% | +$3.84M | 0.18% | 123 |
|
2021
Q3 | $11.7M | Sell |
64,237
-825
| -1% | -$150K | 0.12% | 184 |
|
2021
Q2 | $13.1K | Buy |
65,062
+30,865
| +90% | +$6.22K | 0.12% | 164 |
|
2021
Q1 | $7.35M | Sell |
34,197
-15,513
| -31% | -$3.33M | 0.07% | 253 |
|
2020
Q4 | $11.7M | Buy |
+49,710
| New | +$11.7M | 0.17% | 142 |
|
2018
Q3 | – | Sell |
-1,537
| Closed | -$261K | – | 707 |
|
2018
Q2 | $261K | Buy |
+1,537
| New | +$261K | ﹤0.01% | 415 |
|
2017
Q4 | – | Sell |
-3,212
| Closed | -$488K | – | 888 |
|
2017
Q3 | $488K | Buy |
+3,212
| New | +$488K | 0.01% | 433 |
|
2016
Q4 | – | Sell |
-10,205
| Closed | -$890K | – | 368 |
|
2016
Q3 | $890K | Buy |
+10,205
| New | +$890K | 0.01% | 266 |
|